has been fortunate over the years to work with the following companies: Abbott, ARC, Aventis, Astra Zeneca, Bristol-Meyers Squibb, Cephalon, Covance, CTMS, Esperion, Forest, Glaxo Smith Kline, Icon, INC, i3Research, Janssen, Johnson & Johnson, Kendle, Lilly, Lundbeck, MDS, Merck, Neurocrine, Novartis, Ominicare, Organon, Otsuka, Parexel, Parke-Davis, Pfizer, Pharmacia, Pharmanet, PPD, Quintiles, Sanofi, Scirex, Shire, Solvay, Sumitomo, Takeda, TAP, Vela Pharm, Wyeth and others. We appreciate the trust these companies have placed in SYNERGY, and look forward to rewarding that trust everyday.

 

We have conducted over 100 outpatient and inpatient trials since 1997 focused on the following diagnoses: Schizophrenia, Bipolar disorder, Depression, Geriatric depression, Alzheimers disease, Sexual dysfunction, Dementia, G.A.D., Schizoaffective disorder, Post traumatic stress disorder, O.C.D. (adolescent and adult), Panic disorder, Social phobia, Tardive dyskinesia, Cognitive function, Agitation, Asthma, I.B.S., Diabetes, Bronchitis, Hypertension, Insomnia, Sleep Disorders, Flu, Pain, Weight loss, Gerd, Dermatitis, Lipid lowering, Arthritis, Gyn disorders & more.